Our Team
Rob Royea
CEO & Co-FounderListed as one of the Top 40 Medical Transformers for 2016 by Medical Marketing and Management Magazine. Led global efforts of both public and private venture technologies, with demonstrated successes from start-up to over $550M. Positioned Cyrcadia to earn the prestigious Edison award in 2016 as the #1 company in Health and Wellness, Wearable and Sensors Category.
Mark Chennells
Co-Founder & DirectorSpecialised in corporate mergers, acquisitions and restructurings in NZ, Australia, USA, UK and China. Brings over 20 years experience advising and investing in China, during which time he has helped to found several companies and has advised a number of Chinese companies on their international acquisitions.
Chris Bailey
Co-Founder & DirectorChris’ professional experience includes acting as an Executive with the IP specialist firm, Rouse (www.rouse.com). Chris brings 18 years of experience in advising overseas companies on the management, protection and commercialisation of their IP assets in China and other countries in Asia.
Dr. Shyamali Singhal
Chief Medical OfficerM.D. & Ph.D. in Molecular Pharmacology from Albert Einstein College of Medicine. Specializes in surgical oncology for the treatment breast, melanoma, colon, stomach, liver and pancreatic cancer.
Dr. Vinitha Subbhuraam
Director - Analytic Core LabPh.D. in Biomedical Engineering at Nanyang Technological University of Singapore. Brings 10+ years of experience in the medical analytics field, in applied predictive algorithms for the detection of cancers in the breast, ovaries, prostate and thyroid.
Tang Ying
Director - Business DevelopmentStrong background in media and healthcare transactions in China including the formation of Yuxin Media and Cyrcadia Asia.
Dr. Claudia S. Dyckerhoff
DirectorPhD in business administration and an MBA. Formerly a senior partner at McKinsey with over 10 years of experience in the Asian healthcare and health insurance sectors, leading McKinsey’s China Healthcare Sector team and its Asian Health Services and Systems team until stepping down in 2016. Is currently a Director of Roche AG and Clariant AG.
Rob Royea
CEO & Co-FounderListed as one of the Top 40 Medical Transformers for 2016 by Medical Marketing and Management Magazine. Led global efforts of both public and private venture technologies, with demonstrated successes from start-up to over $550M. Positioned Cyrcadia to earn the prestigious Edison award in 2016 as the #1 company in Health and Wellness, Wearable and Sensors Category.
Mark Chennells
Co-Founder & DirectorSpecialised in corporate mergers, acquisitions and restructurings in NZ, Australia, USA, UK and China. Brings over 20 years experience advising and investing in China, during which time he has helped to found several companies and has advised a number of Chinese companies on their international acquisitions.
Chris Bailey
Co-Founder & DirectorChris’ professional experience includes acting as an Executive with the IP specialist firm, Rouse (www.rouse.com). Chris brings 18 years of experience in advising overseas companies on the management, protection and commercialisation of their IP assets in China and other countries in Asia.
Dr. Shyamali Singhal
Chief Medical OfficerM.D. & Ph.D. in Molecular Pharmacology from Albert Einstein College of Medicine. Specializes in surgical oncology for the treatment breast, melanoma, colon, stomach, liver and pancreatic cancer.
Dr. Vinitha Subbhuraam
Director - Analytic Core LabPh.D. in Biomedical Engineering at Nanyang Technological University of Singapore. Brings 10+ years of experience in the medical analytics field, in applied predictive algorithms for the detection of cancers in the breast, ovaries, prostate and thyroid.
Tang Ying
Director - Business DevelopmentStrong background in media and healthcare transactions in China including the formation of Yuxin Media and Cyrcadia Asia.
Dr. Claudia S. Dyckerhoff
DirectorPhD in business administration and an MBA. Formerly a senior partner at McKinsey with over 10 years of experience in the Asian healthcare and health insurance sectors, leading McKinsey’s China Healthcare Sector team and its Asian Health Services and Systems team until stepping down in 2016. Is currently a Director of Roche AG and Clariant AG.